Dr. Lea Watson covers two drugs, Nuplazid and the new one approved by the FDA, Aducanumab. Followed by Dr. Sing Palat, CMD and new President of CMDA who discusses the use of oxygen with nocturnal hypoxemia in COPD.
Recording Date: 5/6/2021
Available Credit
FMDA Journal Club | COVID-19: Current State, Challenges, and Opportunities
JAMDA ON-THE-GO | June 2020
AMDA ON-THE-HILL | COVID - 19 UPDATE | VOLUME XV
FMDA Journal Club | Telehealth in the Time of Pandemic in PALTC
FMDA Journal Club | COVID-19: Evolving Our Infection Control Policies and Response, June 3, 2020
FMDA Journal Club | COVID-19: Behavioral Health Impact
FMDA Journal Club | Clinical Deep Dive into the Research | 5/20/2020
AMDA On-The-Go | Medication Management during COVID-19
AMDA On-The-Hill | COVID - 19 UPDATE | VOLUME XIV
FMDA Journal Club | COVID-19: Stories from the Front Lines
JAMDA On-The-Go | May 2020 | COVID-19 Pandemic
AMDA On-The-Go | POLST in the Time of COVID-19
AMDA On-The-Go | Rehabbed to Death
FMDA Journal Club | COVID-19: Advance Care Planning
FMDA Journal Club | Treating COVID-19 Patients in Place: Clinical Deep Dive into the Research
AMDA On-The-Go | Behavioral Health Effects of COVID-19
AMDA ON-THE-HILL | COVID - 19 Update | VOLUME XIII
FMDA Journal Club | Treating COVID-19 Patients in Place in PALTC: Facility Readiness (Part 3)
FMDA Journal Club | Treating COVID-19 Residents in Place | April 8
AMDA On-The-Go | Ethical Issues and Advanced Care Planning in the COVID-19 Environment
Create your
podcast in
minutes
It is Free
The Meaningful Life with Andrew G. Marshall
The No-Frills Teacher Podcast
Heal, Survive & Thrive!
The Jordan B. Peterson Podcast
The Mel Robbins Podcast